Preparation method of chrysoeriol

A technology of coirisin and medicinal materials, which is applied in the field of coirisin preparation, can solve the problems of low extraction rate and large loss of coirisin, and achieve the effects of short extraction time, easy control and prolonged service life
CN101973974AInactive Publication Date: 2011-02-16NANJING ZELANG MEDICAL TECH

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
NANJING ZELANG MEDICAL TECH
Publication Date
2011-02-16
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
Patent Text Reader

Abstract

The invention provides a preparation method of chrysoeriol. A high-purity chrysoeriol product is obtained by the steps of alkali extraction and water precipitation, organic solvent extraction, membrane concentration, macroporous resin adsorption, and the like. In a membrane separation process, not only the product purity is improved, but also the damage to resin is alleviated, and the service life of the resin is prolonged; and by adopting crystallization and recrystallization, the purification efficiency is high. The whole preparation process has the advantages that requirements on environment and equipment are low, extraction and separation time is short, purity is high and the preparation method is simple and easy to operate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention belongs to the field of medicine and chemical industry, and relates to a preparation method of coelisol. Background technique:

[0002] Coelisu

[0003] English name: Chrysoeriol, molecular formula: C 16 H 12 O 6 ; Molecular weight: 300.26;

[0004] Molecular structural formula:

[0005]

[0006] Coelitin is a pale yellow powder, mp. 320-322°C (mp. 336-337°C is also reported). Soluble in chloroform, ethyl acetate and other organic solvents.

[0007] Medicinal effects: anti-tumor (inhibits the carcinogenic effect of 3,4-benzopyrene, inhibits the metabolism of benzopyrene); cytotoxicity (P388, ED 50 =1.9 μg / ml); cAMP phosphodiesterase inhibitor (in vitro, IC 50 = 269 μmol / L); anti-allergic and anti-inflammatory (inhibit basophils to release histamine, inhibit neutrophils to release β-glucuronidase); aldose reductase inhibitor (10 μmol / L inhibition rate 31.3%); xanthine Oxidase inhibitor (50μg / ml inhibition rate 61.5%, IC 50 = ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More